2.5.15
SWHR Statement in Appreciation for Commissioner Hamburg’s Service
SWHR commends the outgoing Food and Drug Administration (FDA) Commissioner, Dr. Margaret Hamburg, for her profound service to improve American public health at the Agency.
2.2.15
SWHR Statement on President’s Budget and Precision Medicine Initiative
President Barack Obama unveiled his budget request to Congress for the 2016 fiscal year, which provides for critical investment in research at our Nation’s premier science agencies.
1.27.15
DeLauro NIH Funding Bill Will Provide Critically Needed Investments in Medical Research
Statement from Phyllis Greenberger, President and CEO of the Society for Women’s Health Research
1.27.15
SWHR Submits comments to FDA Regarding Drug Trials Snapshots
The U.S. Food and Drug Administration (FDA) recently created Drug Trials Snapshots, a new website to give patients, providers, and caregivers information on the participation of people in clinical trials by sex, age, race, and ethnicity.
12.4.14
FDA Issues Final Rule on Pregnancy and Lactation Labeling
The Food and Drug Administration announced a final rule today that sets new standards for labeling information for prescription drugs and biological products.
10.17.14
SWHR Salutes the FDA Office of Women’s Health on 20 Years of Advancing Women’s Health
SWHR congratulates the Food and Drug Administration’s (FDA) Office of Women’s Health for 20 years of working to improve the health of women.
10.17.14
OSSD Offers Recommendations to Basic Scientists on New NIH Research Policies
SWHR would like to congratulate several leading members of the Organization for the Study of Sex Differences (OSSD) on the publication of their recent article "NIH initiative to balance sex of animals in preclinical studies: Generative questions to guide policy, implementation, and metrics."
10.17.14
SWHR Applauds NIH-funded Research on Gender Bias in Pre-clinical and Clinical Studies
The National Institutes of Health (NIH) announced that it will invest $10.1 million in supplemental funding to support the research of more than 80 grantees to investigate the effects of sex in pre-clinical and clinical studies.
